At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BJDX Bluejay Diagnostics Inc
Pre-Market Trading 12-23 05:34:21 EST
3.84
-0.06
-1.54%
High4.14
Low3.73
Vol25.77K
Open3.85
D1 Closing3.90
Amplitude10.51%
Mkt Cap2.06M
Tradable Cap2.06M
Total Shares537.68K
T/O102.20K
T/O Rate4.80%
Tradable Shares536.57K
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Wall Street to Open Slightly Higher Friday as Payrolls Data Tops Forecasts
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.